New cool climate fruit crop in Canada has potential as anticancer super food
the ONA take:
Hippocrates, the father of medicine, stated, “Let thy food be thy medicine and thy medicine be thy food.”
Researchers in Canada are taking those words to heart and have begun a new research initiative on the disease fighting power of haskap, the newest cool climate fruit crop in Nova Scotia. Haskap is also known as blue honeysuckle or honeyberry; it is a small blue berry similar to a blueberry.
Vasantha Rupasinghe, Canada Research Chair in Fruit Bioactives and BioProducts, is leading the team in this initiative. The fruit, which is rich in dietary antioxidants such as flavonoids, has potential to fight cancer if consumed daily along with other healthy lifestyle practices.
Their investigations include testing the anticancer activity of haskap bioactives on lung cancer cells; developing a manufacturing process that will optimize retention of the bioactives, vitamins, and anthocyanins in the fruit; and exploring its potential as a cancer-preventive food product.
The berry is new Canada; however, it has been used to treat many diseases in other countries such as Northern Russia, Japan, and China.
The research team is also working with LaHave Forests Farm, which has 60 acres of haskap orchards and plans to expand its orchards as well as sell plants to other farmers in Nova Scotia to encourage expanding the supply of the fruit.
The fruit has potential to fight cancer if consumed daily along with other healthy lifestyle practices.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|